339 related articles for article (PubMed ID: 27197423)
1. PTTG and Ki-67 expression in pituitary adenomas.
Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
[TBL] [Abstract][Full Text] [Related]
2. Prothymosin-alpha and Ki-67 expression in pituitary adenomas.
Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
Postepy Hig Med Dosw (Online); 2016 Nov; 70(0):1117-1123. PubMed ID: 27892895
[TBL] [Abstract][Full Text] [Related]
3. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
4. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
5. The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.
Hunter JA; Skelly RH; Aylwin SJ; Geddes JF; Evanson J; Besser GM; Monson JP; Burrin JM
Eur J Endocrinol; 2003 Feb; 148(2):203-11. PubMed ID: 12590639
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas.
Gruppetta M; Formosa R; Falzon S; Ariff Scicluna S; Falzon E; Degeatano J; Vassallo J
Pituitary; 2017 Jun; 20(3):358-371. PubMed ID: 28342098
[TBL] [Abstract][Full Text] [Related]
7. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.
Ozkaya HM; Comunoglu N; Keskin FE; Oz B; Haliloglu OA; Tanriover N; Gazioglu N; Kadioglu P
Endocrine; 2016 Jun; 52(3):632-40. PubMed ID: 26578364
[TBL] [Abstract][Full Text] [Related]
8. PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age.
Trott G; Ongaratti BR; de Oliveira Silva CB; Abech GD; Haag T; Rech CGSL; Ferreira NP; da Costa Oliveira M; Pereira-Lima JFS
Ann Diagn Pathol; 2019 Aug; 41():83-89. PubMed ID: 31154064
[TBL] [Abstract][Full Text] [Related]
9. Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour.
McCabe CJ; Khaira JS; Boelaert K; Heaney AP; Tannahill LA; Hussain S; Mitchell R; Olliff J; Sheppard MC; Franklyn JA; Gittoes NJ
Clin Endocrinol (Oxf); 2003 Feb; 58(2):141-50. PubMed ID: 12580928
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
[TBL] [Abstract][Full Text] [Related]
11. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
12. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
Lath R; Chacko G; Chandy MJ
Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
14. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.
Ekramullah SM; Saitoh Y; Arita N; Ohnishi T; Hayakawa T
Acta Neurochir (Wien); 1996; 138(12):1449-55. PubMed ID: 9030353
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas.
Grimm F; Maurus R; Beschorner R; Naros G; Stanojevic M; Gugel I; Giese S; Bier G; Bender B; Honegger J
Acta Neurochir (Wien); 2019 Jun; 161(6):1149-1156. PubMed ID: 31037500
[TBL] [Abstract][Full Text] [Related]
16. Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis.
Tena-Suck ML; Ortiz-Plata A; de la Vega HA
Ann Diagn Pathol; 2008 Aug; 12(4):275-282. PubMed ID: 18620995
[TBL] [Abstract][Full Text] [Related]
17. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
18. PTTG-1 (Securin) immunoexpression in meningiomas correlates with tumor grade and proliferation rate: potential use as a diagnostic marker of malignancy.
Iliadis A; Virvili MA; Flaris NA; Pervana S; Pazarli E; Tripsianis G; Grigoriou ME; Efstratiou I; Kanakis DN
APMIS; 2018 Apr; 126(4):295-302. PubMed ID: 29575197
[TBL] [Abstract][Full Text] [Related]
19. Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53.
Kasuki Jomori de Pinho L; Vieira Neto L; Armondi Wildemberg LE; Gasparetto EL; Marcondes J; de Almeida Nunes B; Takiya CM; Gadelha MR
Neuroendocrinology; 2011; 94(1):39-48. PubMed ID: 21178332
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
